Metiapine

a double blind comparison with chlorpromazine in acute schizophrenic patients

R. M. Steinbook, B. J. Goldstein, B. Brauzer, A. F. Jacobson, S. S. Moreno

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sixty newly admitted acute schizophrenic patients were randomly assigned to a double blind trial of metiapine with a maximum dose of 450 mg per day vs a maximum daily dose of 900 mg chlorpromazine per day. At the conclusion of the study, 21 patients in each group showed marked to moderate improvement. There were significantly more marked improvers in the metiapine group than in the chlorpromazine group on the Physician's Posttreatment Global Impression. Evaluation by analysis of covariance of the Brief Psychiatric Rating Scale showed a significant difference between treatment groups favoring chlorpromazine on the item of blunted affect. The spectrum of side effects was similar in the two groups, except for six patients treated with metiapine who displayed tachycardia on the EKG. This pulse elevation was reflected in the group data and is probably dose related. In conclusion, both drugs appeared to be equally efficacious in the treatment of newly admitted acute schizophrenic patients.

Original languageEnglish
Pages (from-to)700-704
Number of pages5
JournalJournal of Clinical Pharmacology
Volume15
Issue number10
StatePublished - Dec 1 1975
Externally publishedYes

Fingerprint

Chlorpromazine
Brief Psychiatric Rating Scale
Tachycardia
Pulse
Electrocardiography
Physicians
metiapine
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Steinbook, R. M., Goldstein, B. J., Brauzer, B., Jacobson, A. F., & Moreno, S. S. (1975). Metiapine: a double blind comparison with chlorpromazine in acute schizophrenic patients. Journal of Clinical Pharmacology, 15(10), 700-704.

Metiapine : a double blind comparison with chlorpromazine in acute schizophrenic patients. / Steinbook, R. M.; Goldstein, B. J.; Brauzer, B.; Jacobson, A. F.; Moreno, S. S.

In: Journal of Clinical Pharmacology, Vol. 15, No. 10, 01.12.1975, p. 700-704.

Research output: Contribution to journalArticle

Steinbook, RM, Goldstein, BJ, Brauzer, B, Jacobson, AF & Moreno, SS 1975, 'Metiapine: a double blind comparison with chlorpromazine in acute schizophrenic patients', Journal of Clinical Pharmacology, vol. 15, no. 10, pp. 700-704.
Steinbook RM, Goldstein BJ, Brauzer B, Jacobson AF, Moreno SS. Metiapine: a double blind comparison with chlorpromazine in acute schizophrenic patients. Journal of Clinical Pharmacology. 1975 Dec 1;15(10):700-704.
Steinbook, R. M. ; Goldstein, B. J. ; Brauzer, B. ; Jacobson, A. F. ; Moreno, S. S. / Metiapine : a double blind comparison with chlorpromazine in acute schizophrenic patients. In: Journal of Clinical Pharmacology. 1975 ; Vol. 15, No. 10. pp. 700-704.
@article{af2762511c0b47e2a2692ef27a9cad6f,
title = "Metiapine: a double blind comparison with chlorpromazine in acute schizophrenic patients",
abstract = "Sixty newly admitted acute schizophrenic patients were randomly assigned to a double blind trial of metiapine with a maximum dose of 450 mg per day vs a maximum daily dose of 900 mg chlorpromazine per day. At the conclusion of the study, 21 patients in each group showed marked to moderate improvement. There were significantly more marked improvers in the metiapine group than in the chlorpromazine group on the Physician's Posttreatment Global Impression. Evaluation by analysis of covariance of the Brief Psychiatric Rating Scale showed a significant difference between treatment groups favoring chlorpromazine on the item of blunted affect. The spectrum of side effects was similar in the two groups, except for six patients treated with metiapine who displayed tachycardia on the EKG. This pulse elevation was reflected in the group data and is probably dose related. In conclusion, both drugs appeared to be equally efficacious in the treatment of newly admitted acute schizophrenic patients.",
author = "Steinbook, {R. M.} and Goldstein, {B. J.} and B. Brauzer and Jacobson, {A. F.} and Moreno, {S. S.}",
year = "1975",
month = "12",
day = "1",
language = "English",
volume = "15",
pages = "700--704",
journal = "Journal of Clinical Pharmacology",
issn = "0091-2700",
publisher = "SAGE Publications Inc.",
number = "10",

}

TY - JOUR

T1 - Metiapine

T2 - a double blind comparison with chlorpromazine in acute schizophrenic patients

AU - Steinbook, R. M.

AU - Goldstein, B. J.

AU - Brauzer, B.

AU - Jacobson, A. F.

AU - Moreno, S. S.

PY - 1975/12/1

Y1 - 1975/12/1

N2 - Sixty newly admitted acute schizophrenic patients were randomly assigned to a double blind trial of metiapine with a maximum dose of 450 mg per day vs a maximum daily dose of 900 mg chlorpromazine per day. At the conclusion of the study, 21 patients in each group showed marked to moderate improvement. There were significantly more marked improvers in the metiapine group than in the chlorpromazine group on the Physician's Posttreatment Global Impression. Evaluation by analysis of covariance of the Brief Psychiatric Rating Scale showed a significant difference between treatment groups favoring chlorpromazine on the item of blunted affect. The spectrum of side effects was similar in the two groups, except for six patients treated with metiapine who displayed tachycardia on the EKG. This pulse elevation was reflected in the group data and is probably dose related. In conclusion, both drugs appeared to be equally efficacious in the treatment of newly admitted acute schizophrenic patients.

AB - Sixty newly admitted acute schizophrenic patients were randomly assigned to a double blind trial of metiapine with a maximum dose of 450 mg per day vs a maximum daily dose of 900 mg chlorpromazine per day. At the conclusion of the study, 21 patients in each group showed marked to moderate improvement. There were significantly more marked improvers in the metiapine group than in the chlorpromazine group on the Physician's Posttreatment Global Impression. Evaluation by analysis of covariance of the Brief Psychiatric Rating Scale showed a significant difference between treatment groups favoring chlorpromazine on the item of blunted affect. The spectrum of side effects was similar in the two groups, except for six patients treated with metiapine who displayed tachycardia on the EKG. This pulse elevation was reflected in the group data and is probably dose related. In conclusion, both drugs appeared to be equally efficacious in the treatment of newly admitted acute schizophrenic patients.

UR - http://www.scopus.com/inward/record.url?scp=0016685296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016685296&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 700

EP - 704

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

SN - 0091-2700

IS - 10

ER -